Thomas Knapp was Promoted as Senior Vice President and General Counsel at Ascentage-Pharma

Date of management change: March 18, 2019 

What Happened?

Rockville, -based Ascentage-Pharma Promoted Thomas Knapp as Senior Vice President and General Counsel

 

About the Company

Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company`s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors.

 

About the Person

Thomas Knapp is Senior Vice President of Legal Affairs at Ascentage Pharma. Previously, Thomas held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Barakat Charbel, Longobardo Ryan, Spicer Katherine, Morris Jason, Johnson Beth, Williams Kayla, Mattson Joel, Kiely-becchetti Kathleen, Butler Tobias, Merchant Thomas, Moore Richard

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.